ADC Therapeutics SA share price logo

ADC Therapeutics SA Share Price

NYSE: ADCT

Small Cap

$3.67

-0.10

(-2.78%)

as on

ADC Therapeutics SA Stock Performance

as on April 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.66
    $3.83
    downward going graph

    0.27%

    Downside

    4.36%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.05
    $4.98
    downward going graph

    71.39%

    Downside

    35.69%

    Upside

    downward going graph

ADC Therapeutics SA share price movements today

Previous Close
$3.78
Open
$3.76
Volume
882.9K
Day's Low - High
$3.66 - $3.83
52 Week Low - High
$1.05 - $4.98

ADC Therapeutics SA Historical Returns

1 Month Return
-8.03 %
3 Month Return
+ 6.78 %
1 Year Return
+ 220.34 %
3 Year Return
+ 85.29 %
5 Year Return
-85.97 %

ADC Therapeutics SA Stock Fundamentals & Key Indicators

Check ADC Therapeutics SA market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$480.2M

EPS (TTM)

-0.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-105.4M

Revenue (TTM)

81.4M

Profit Margin

-175.31%

Return On Equity TTM

-705.53%

ADC Therapeutics SA vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ADC Therapeutics SA with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ADC Therapeutics SA image
ADC Therapeutics SA
BUY$480.2M-85.97%NA-175.31%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.53%136.858.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B103.77%28.6632.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA126.855.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B59.16%18.3831.41%

Stock Returns calculator for ADC Therapeutics SA Stock including INR - Dollar returns

The ADC Therapeutics SA stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ADC Therapeutics SA investment value today

Current value as on today

₹3,37,014

Returns

₹2,37,014

(+237.01%)

Returns from ADC Therapeutics SA Stock

₹2,11,017 (+211.02%)

Dollar Impact

₹25,997 (+26%)

Analyst Recommendation on ADC Therapeutics SA Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for ADC Therapeutics SA. Average target price of $8.2

ADC Therapeutics SA Share Price Target

Get share price movements and forecasts by analysts on ADC Therapeutics SA.

What analysts predicted

55.24%UPSIDE

Target Price

$8.2

Current Price

$3.67

Analyzed by

12 Analysts

Target

$8.20

ADC Therapeutics SA target price $8.2, a slight upside of 55.24% compared to current price of $3.67. According to 12 analysts rating.

ADC Therapeutics SA Stock’s Investor Sentiment and Interest

Search interest for ADC Therapeutics SA Stock has increased by 109% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:109% versus previous 30 day period

ADC Therapeutics SA Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
14
16
18
17
18
16
23
18
16
23
Gross Profit
14
-108
15
16
17
15
20
18
15
19
Operating Income
-37
-39
-33
-29
-35
-32
-28
-44
-30
-4
EBITDA
-32
-39
-32
-22
-29
-18
-25
-41
-27
-11
Interest Expense
12
7
12
12
13
11
12
12
13
13
Depreciation
0
1
0
0
0
0
0
0
0
0
Income Before Tax
-47
-41
-46
-36
-43
-31
-38
-55
-40
-7
Income Tax Expense
0
43
0
0
0
0
0
1
-
0
Net Income
-47
-85
-46
-36
-43
-30
-38
-56
-40
-6
Net Profit Margin
-329.86%
-506.44%
-258.16%
-209.90%
-238.13%
-181.71%
-167.59%
-300.68%
-249.38%
-27.80%

ADC Therapeutics SA Annual Profit & Loss

All numbers in Millions USD

Sep 2020
Dec 2020
Sep 2021
Dec 2021
Sep 2022
Dec 2022
Sep 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
33
33
209
209
69
69
70
81
Gross Profit
-
-141
-
32
-
206
-
67
64
73
Operating Income
-
-219
-
-261
-
-123
-
-165
-130
-108
EBITDA
-
-218
-
-230
-
-107
-
-145
-102
-106
Interest Expense
-
4
-
18
-
36
-
46
50
51
Depreciation
-
2
-
2
-
2
-
2
3
1
Income Before Tax
-
-245
-
-251
-
-156
-
-200
-157
-142
Income Tax Expense
-
0
-
-21
-
0
-
39
0
0
Net Income
-246
-246
-230
-230
-155
-157
-240
-240
-157
-142
Net Profit Margin
0.00%
0.00%
-678.20%
-678.20%
-74.22%
-74.86%
-345.11%
-345.11%
-222.83%
-175.31%

ADC Therapeutics SA Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-85
-46
-36
-43
-30
-38
-56
-40
-6
Operating Cash Flow
-31
-44
-32
-25
-21
-56
-24
-29
-31
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
98
0
-1
0
93
0
58
Change in Cash
-31
-44
65
-25
-23
-56
69
-29
26

ADC Therapeutics SA Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-123
-116
-246
-230
-157
-240
-157
-142
Operating Cash Flow
-121
-121
-168
-233
-138
-118
-123
-141
Investing Cash Flow
-2
-2
-2
-6
0
-3
0
0
Financing Cash Flow
0
100
494
267
0
73
97
150
Change in Cash
-123
-23
323
27
-140
-47
-27
10

Global Institutional Holdings in ADC Therapeutics SA

Funds
Holdings
Redmile Group, LLC
12.33%
Junked Platinum Investment Management Ltd
0.91%
JPMorgan Chase & Co
0.52%
Heights Capital Management Inc
2.52%
Woodline Partners LP
0.75%
See all

Insights on ADC Therapeutics SA

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 16.42M → 23.05M (in $), with an average increase of 28.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -56.64M → -6.40M (in $), with an average increase of 288.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ADCT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ADCT stock has moved up by 220.3%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADCT has outperformed top 5 stocks with highest market-cap in its industry

About ADC Therapeutics SA

adc therapeutics is a biotechnology company located in lausanne, vaud, switzerland.
OrganisationADC Therapeutics SA
HeadquartersBiopOle, Epalinges, Switzerland, 1066
IndustryHealth Technology
CEODr. Ameet Mallik M.B.A., M.S.
E-voting on sharesClick here to vote

Key Management of ADC Therapeutics SA

Name

Title

Ms. Kimberly Pope

Senior VP & Chief People Officer

Ms. Kristen Harrington-Smith

Chief Commercial Officer

Mr. Jose I. Carmona M.B.A.

Chief Financial Officer

Dr. Patrick van Berkel Ph.D.

Chief Scientific Officer

Ms. Lisa Michelle Kallebo

Corporate Controller & Chief Accounting Officer

Dr. David S. Ege Ph.D.

Chief Technical Officer

Ms. Nicole Riley

Head of Investor Relations & Corporate Communications

Dr. Ameet Mallik M.B.A., M.S.

CEO & Director

Mr. Peter J. Graham Esq.

Secretary & Chief Legal Officer

Dr. Mohamed Zaki M.D., Ph.D.

Chief Medical Officer

FAQs

What is ADC Therapeutics SA share price today?

ADC Therapeutics SA share price today is $3.67 as on at the close of the market. ADC Therapeutics SA share today touched a day high of $3.83 and a low of $3.66.

What is the 52 week high and 52 week low for ADC Therapeutics SA share?

ADC Therapeutics SA share touched a 52 week high of $4.98 on and a 52 week low of $1.05 on . ADC Therapeutics SA stock price today i.e. is closed at $3.67,which is 26.31% down from its 52 week high and 249.52% up from its 52 week low.

What is ADC Therapeutics SA's market capitalisation today?

ADC Therapeutics SA market capitalisation is $0.00T as on .

How to invest in ADC Therapeutics SA Stock (ADCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ADC Therapeutics SA on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ADC Therapeutics SA Shares that will get you 0.4087 shares as per ADC Therapeutics SA share price of $3.67 per share as on April 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy ADC Therapeutics SA Stock (ADCT) from India?

Indian investors can start investing in ADC Therapeutics SA (ADCT) shares with as little as ₹93.06 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.60 in ADC Therapeutics SA stock (as per the Rupee-Dollar exchange rate as on ). Based on ADC Therapeutics SA share’s latest price of $3.67 as on April 7, 2026 at 1:29 am IST, you will get 2.7248 shares of ADC Therapeutics SA. Learn more about fractional shares .

What are the returns that ADC Therapeutics SA has given to Indian investors in the last 5 years?

ADC Therapeutics SA stock has given -85.97% share price returns and 26.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?